Morning Trend | ALI HEALTH approaches support with increased volume, is a short-term rebound window coming?

Alibaba Health (241.HK) has recently faced continuous pressure in the market, with the stock price nearing the key technical support level of 5.49 yuan after last Friday's close, ending several days of decline. From a funding perspective, the main operators are becoming cautious, with a significant reduction in trading volume; however, there was a gradual warming of short-term buying near the close, indicating that some funds are attempting to enter at low prices within the key support range. The pharmaceutical sector has shown considerable volatility overall, with expectations of policy recovery gradually fermenting, especially with frequent news regarding national medical insurance negotiations and new internet healthcare policies, providing potential speculation space for leading stocks in the sector. From a technical standpoint, Alibaba Health's MACD remains in a death cross state, and the short-term moving average system shows a clear bearish arrangement, indicating a heavy bearish atmosphere. However, after a phase of adjustment, short-term oversold signals are becoming increasingly evident. If there is a volume surge during today's trading, a pulse-like rebound cannot be ruled out, but the overall trend has not undergone substantial changes. Investors are generally focused on whether the 5.49 yuan support can hold; if it breaks down with increased volume, it may trigger a new round of downward space. The ability of the market to stabilize in the short term will require continuous tracking of policy news and the flow of funds. Right-side trading suggestions still need to pay attention to position control to prevent risks. Overall, at this stage, Alibaba Health is still in a range of bottoming and probing, and investors should avoid blindly chasing highs and cutting losses, needing to further observe the gains and losses of support levels and changes in sentiment within the pharmaceutical sector